Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial.

Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial.

<h4>Background</h4> <p>Human immunodeficiency virus (HIV)-related chronic lung disease (CLD) among children is associated with substantial morbidity, despite antiretroviral therapy. This may be a consequence of repeated respiratory tract infections and/or dysregulated immune activ...

Full description

Bibliographic Details
Main Authors: Gonzalez-Martinez, C, Kranzer, K, McHugh, G, Corbett, E, Mujuru, H, Nicol, M, Rowland-Jones, S, Rehman, A, Gutteberg, T, Flaegstad, T, Odland, J, Ferrand, R, BREATHE study team
Format: Journal article
Language:English
Published: BioMed Central 2017

Similar Items

Similar Items